A hospice in GA. It ran an operating loss of 55.1% in FY22 on $0.8M of operating revenue. It held 19 days of cash on hand (37th percentile among hospices on liquidity). Only a single comparable reporting year is available, so trend context is limited.
Days cash on hand · FY22
19d
all sources
vs hospices37th pctl of 2,345 (FY22)
Total operating revenue · FY22
$0.8M
vs hospices16th pctl of 3,459 (FY22)
Operating margin · FY22
-55.1%
vs hospices6th pctl of 3,198 (FY22)
Total days of care
5560.0d
Verified fact2022
Source: HCRIS CMS-1984
Benchmarked within its own FY22 pool (n=3,198); the hospice cohort's current year is FY24.
Where available_in_s100000_line_1_col_1_suppressed sits among hospices
Operating margin · FY22 pool · n = 3,198 of 5,626 filed
Each point is one hospice in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The hospice median is -1.3%. Descriptive context only, not a ranking.
Benchmarked within its own FY22 pool (n=3,198); the hospice cohort's current year is FY24.
One hospiceavailable_in_s100000_line_1_col_1_suppressedhospice median
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gated
Ratios tell you how this hospice is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.
Operating margin
-55.1% (FY22)
Operating income ÷ total operating revenue
HCRIS WS G-3
Total margin
-55.1% (FY22)
Net income ÷ total revenue incl. nonoperating
HCRIS WS G-3
Days cash on hand
19d (FY22)
Cash & investments ÷ daily operating expense
HCRIS WS G / G-3
Current ratio
21.67× (FY22)
Total current assets ÷ current liabilities
HCRIS WS G
Equity financing ratio
4% (FY22)
Total net assets ÷ total assets
HCRIS WS G
Days in net patient A/R
Not reported in this filing
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
HCRIS WS G / G-3
$ in thousands
Line item
FY20
FY21
FY22
Patient revenue
2,414
1,700
833
Total operating revenue
2,414
1,700
833
Total operating expenses
2,083
1,852
1,291
Operating income
331
(152)
(459)
Operating margin %
+13.7%
-8.9%
-55.1%
Other non-operating, net
83
0
0
Net income
414
(152)
(459)
Net income %
+16.6%
-8.9%
-55.1%
HCRIS CMS-1984 cost report · $ thousands · FY20–FY22 · patient-service operating basis; non-patient revenue (contributions, investment) is non-operating · FY20–21 may include COVID-era relief funding
How it operates
quality & operational context · CMS public reporting
The metrics this hospice type is judged on: care quality, patient experience, and scale. Each is labeled by evidence class and public source; descriptive context only, never a ranking or adequacy claim.
Routine home care mix
100.0%
Verified fact2022
HCRIS CMS-1984
Respite mix
0.0%
Verified fact2022
HCRIS CMS-1984
Total days of care
5560.0d
Verified fact2022
HCRIS CMS-1984
Continuous home care mix
0.0%
Verified fact2022
HCRIS CMS-1984
General inpatient mix
0.0%
Verified fact2022
HCRIS CMS-1984
Trajectory
Cost-report basis · 3 reporting years
Operating margin
Days cash on hand
The county this hospice serves
Location, GA
County demographic and economic context (Census, CDC, HRSA sources) extends to this hospice cohort in an upcoming release.
Opportunity screen · FY22
≈ $259K
of annual opportunity identified against peer medians across 1 measure
Directional, conservative band. Arithmetic against matched-peer medians from public filings, not a projection; public data cannot fully control for patient acuity.
FY22 has not yet reached pool validity: benchmarked against the FY24 pool (n=4,349).
The free profile shows the record. The Board Briefing tells you what changed, what matters, and what your board should ask. 35+ pages, built entirely from public sources, no client data required. Delivered within 2 business days. If we cannot deliver the published scope for your facility, you pay nothing.
Where this facility is underperforming its matched peer cohort and what that gap is worth, measure by measure. Founding Edition: delivered within 30 days of eligibility confirmation, full refund if the published scope cannot be delivered.
